CRISPR Therapeutics (CRSP) PT Lowered to $60 at RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St climbs as oil slips; SpaceX spectrum deal weighs on telecoms
- Oil falls as Trump comments on Iran talks ease supply concerns
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment deteriorates further in October
- CoreWeave stock drops on dilution fears and debt concerns
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- Oracle and these 6 stocks are newest addition to Mizuho Top Picks list
- Anthropic launches cyber defense program for infrastructure and open-source
Form S-3ASR CRISPR Therapeutics AG
August 5, 2024 5:23 PM EDTTable of Contents
As filed with the Securities and Exchange Commission on August 5,... More
Form S-8 CRISPR Therapeutics AG
August 5, 2024 4:55 PM EDT
As filed with the Securities and Exchange Commission on August 5, 2024... More
Form 8-K CRISPR Therapeutics AG For: Aug 05
August 5, 2024 4:05 PM EDTfalse000167441600-000000000016744162024-08-052024-08-05... More



